ID: ALA5278476

Max Phase: Preclinical

Molecular Formula: C19H20F2N4O2

Molecular Weight: 374.39

Representations

Canonical SMILES:  Nc1ncc(-c2cc(C3CC3)cc(N3C[C@@H]4C[C@H]3CO4)c2)nc1OC(F)F

Standard InChI:  InChI=1S/C19H20F2N4O2/c20-19(21)27-18-17(22)23-7-16(24-18)12-3-11(10-1-2-10)4-13(5-12)25-8-15-6-14(25)9-26-15/h3-5,7,10,14-15,19H,1-2,6,8-9H2,(H2,22,23)/t14-,15-/m0/s1

Standard InChI Key:  PWQYILBUZALMLM-GJZGRUSLSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 374.39

Molecular Weight (Monoisotopic): 374.1554

AlogP: 3.18

#Rotatable Bonds: 5

Polar Surface Area: 73.50

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 1.54

CX LogP: 3.38

CX LogD: 3.38

Aromatic Rings: 2

Heavy Atoms: 27

QED Weighted: 0.87

Np Likeness Score: -0.38

References

1. Craig RA, Fox BM, Hu C, Lexa KW, Osipov M, Thottumkara AP, Larhammar M, Miyamoto T, Rana A, Kane LA, Yulyaningsih E, Solanoy H, Nguyen H, Chau R, Earr T, Kajiwara Y, Fleck D, Lucas A, Haddick PCG, Takahashi RH, Tong V, Wang J, Canet MJ, Poda SB, Scearce-Levie K, Srivastava A, Sweeney ZK, Xu M, Zhang R, He J, Lei Y, Zhuo Z, de Vicente J..  (2022)  Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis.,  65  (24.0): [PMID:36469401] [10.1021/acs.jmedchem.2c01056]

Source

Source(1):

• Scientific Literature